Posts by Raymond J. March
Raymond J. March is a Research Fellow and Director of FDAReview.org with the Independent Institute. He is also an Assistant Professor of Economics at Angelo State University where he is the Assistant Director of the Free Market Institute, Assistant Research Professor at Texas Tech University, Public Choice and Public Policy fellow with the American Institute for Economic Research, and an affiliated scholar with the Challey Institute for Global Innovation and Growth. His research has appeared in Health Economics, Southern Economic Journal, Public Choice, Research Policy, Food Policy, Journal of Institutional Economics, The Independent Review and other academic outlets. His popular articles have appeared in Fortune, Washington Examiner, National Interest, Washington Times, Sun Sentinel, The Hill, Real Clear Health, Medical News Daily. He earned his Ph.D. from Texas Tech University.
FDA Wants More Sunscreen Regulations, but Would Consumers Get Burned?
Raymond J. March  •  Thursday, March 14, 2019
FDA Panel Backs Ketamine-Based Treatment for Depression
Raymond J. March  •  Wednesday, February 27, 2019
Let Competition, Not Politicians, Bring Insulin Prices Down
Raymond J. March  •  Wednesday, February 20, 2019
Right-to-Try Laws Help Patient with Terminal Brain Cancer
Raymond J. March  •  Friday, February 1, 2019
FDA Approves Record Number of Generic Drugs in 2018
Raymond J. March  •  Wednesday, January 9, 2019
Teen Vaping Is Bad, but the Alternative Is Worse
Raymond J. March  •  Tuesday, January 8, 2019
Can the FDA Prevent Teens from Vaping?
Raymond J. March  •  Monday, January 7, 2019
Deregulation Is the Only Cure for High Drug Prices
Raymond J. March  •  Thursday, January 3, 2019
FDA Vaping Regulations Will Do More Harm than Good
Raymond J. March  •  Friday, November 30, 2018
To Help the Terminally Ill, the FDA Must Deregulate
Raymond J. March  •  Thursday, November 15, 2018
When Healthy Policy Neglects Economic Principles, Patients Suffer
Raymond J. March  •  Saturday, October 13, 2018
FDA Still Hooked on Meddling in Nicotine Markets
Raymond J. March  •  Monday, October 8, 2018
FDA Struggles to Develop “Sugar Added” Labels for Honey and Maple Syrup
Raymond J. March  •  Wednesday, September 26, 2018
Let Competition, Not the FDA, Resolve the EpiPen Shortage
Raymond J. March  •  Wednesday, September 12, 2018
Government vs. Private Efforts to Promote Breastfeeding: My Response to a Critic
Raymond J. March  •  Sunday, September 2, 2018
FDA Considers Regulating E-cigarette Juices
Raymond J. March  •  Saturday, September 1, 2018
FDA Approves Medical App for Contraception
Raymond J. March  •  Wednesday, August 22, 2018
Open Up Off-Label Drug Communication and Let the Market Work!
Raymond J. March  •  Tuesday, August 7, 2018
Three Reasons To Be Optimistic about Pharmaceutical Policy
Raymond J. March  •  Thursday, August 2, 2018
If Telemedicine Is Underachieving, Government Is to Blame
Raymond J. March  •  Wednesday, July 11, 2018
Putting Right-to-Try Drug Prices in Perspective
Raymond J. March  •  Monday, July 2, 2018
EpiPen Pricing Controversy Reveals Ignorance about Market Competition
Raymond J. March  •  Friday, June 22, 2018
Dear Congress, Please Don’t Keep Up with the Kardashians!
Raymond J. March  •  Thursday, June 21, 2018
FDA Moves Closer to Approving Ecstasy
Raymond J. March  •  Tuesday, June 19, 2018
Right-to-Try Law Signed!
Raymond J. March  •  Monday, June 18, 2018
« Newer Posts
Older Posts »
  • Catalyst
  • Beyond Homeless
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org
© 2025 INDEPENDENT INSTITUTE, 100 SWAN WAY, OAKLAND CA 94621-1428 | (510) 632-1366 | (510) 568-6040 FAX | SEND EMAIL